Brewin Dolphin LTD Neurocrine Biosciences Inc Transaction History

Brewin Dolphin LTD

  • $2.08 Billion
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Nov 09, 2023
SELL
$89.43 - $102.27 $6,707 - $7,670
-75 Reduced 39.47%
115 $11.2 Million
Q4 2020

Nov 09, 2023
BUY
$86.91 - $108.33 $9,994 - $12,457
115 Added 153.33%
190 $18.2 Million
Q1 2018

Nov 09, 2023
BUY
$75.88 - $92.43 $5,691 - $6,932
75 New
75 $6.22 Million

Others Institutions Holding NBIX

# of Institutions
650
Shares Held
96.2M
Call Options Held
380K
Put Options Held
382K
View Full List

About NEUROCRINE BIOSCIENCES INC

NBIX Quotes by TradingView
  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Brewin Dolphin LTD Portfolio

Follow Brewin Dolphin LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brewin Dolphin LTD, based on Form 13F filings with the SEC.

News

Stay updated on Brewin Dolphin LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email